EUVIMEDEUVIMED entdecken
Crossref

Molecular Engineering of Cordycepin Derivatives for Enhanced Biological Activity and Stability

Yiming Gu, Wei Yu, Xiang Li, Yingjie Fan, Yanan Liu, Jumreang Tummatorn, Siyu Jiang, Jingyue Yang iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202400979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Yiming Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Metastable Materials Science and Technology, Nano-biotechnology Key Lab of Hebei Province, Applying Chemistry Key Lab of Hebe…. Hauptthemen laut MEDLINE: Deoxyadenosines, Antineoplastic Agents, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To address the metabolic instability of cordycepin induced by adenosine deaminase (ADA) and to enhance its bioactivity, this study developed eleven novel cordycepin derivatives using molecular engineering techniques. By incorporating sterically hindered protective groups and modifying the glycosyl moiety, the research aimed to improve both stability and efficacy. Antibacterial tests revealed that five derivatives showed significantly greater activity against pathogenic strains compared to cordycepin, with better compatibility with probiotics. Compound 2 c demonstrated moderate antitumor activity against K562 and MGC‐803 cells, with IC 50 values of 42.21 μM and 27.79 μM, respectively. Additionally, compound 4 b demonstrated notable DPPH free radical scavenging ability. These compounds also showed improved stability in ADA solutions, providing valuable insights into the structure‐activity relationships of cordycepin derivatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeoxyadenosinesAntineoplastic AgentsAnti-Bacterial AgentsHumansStructure-Activity RelationshipMolecular StructureMicrobial Sensitivity TestsDrug Screening Assays, AntitumorCell ProliferationDose-Response Relationship, DrugAdenosine DeaminaseCell Line, Tumor

Stichwörter der Autor:innen

Antibacterial activityAntitumor activityCordycepin derivativesStability against ADA

Substanzen

DeoxyadenosinescordycepinAntineoplastic AgentsAnti-Bacterial AgentsAdenosine Deaminase

Autor:innen und Institutionen

  • State Key Laboratory of Metastable Materials Science and Technology, Nano-biotechnology Key Lab of Hebei Province, Applying Chemistry Key Lab of Hebei Province, Yanshan University, Qinhuangdao, 066004, China.
  • Qinhuangdao Customs Technology Center, Qinhuangdao, Hebei, 066004, China.
  • Laboratory of Medicinal Chemistry, Chulabhorn Research Institute, Bangkok, 10400, Thailand.

ORCID-Profile: Jingyue Yang

Förderung

  • Natural Science Foundation of Hebei

Zitieren

APA

Gu, Y., Yu, W., Li, X., Fan, Y., Liu, Y., Tummatorn, J., Jiang, S., & Yang, J. (2025). Molecular Engineering of Cordycepin Derivatives for Enhanced Biological Activity and Stability. ChemMedChem. https://doi.org/10.1002/cmdc.202400979

Vancouver

Gu Y, Yu W, Li X, Fan Y, Liu Y, Tummatorn J, et al. Molecular Engineering of Cordycepin Derivatives for Enhanced Biological Activity and Stability. ChemMedChem. 2025. doi:10.1002/cmdc.202400979

BibTeX
@article{Gu2025,
  author = {Gu, Yiming and Yu, Wei and Li, Xiang and Fan, Yingjie and Liu, Yanan and Tummatorn, Jumreang and Jiang, Siyu and Yang, Jingyue},
  title = {Molecular Engineering of Cordycepin Derivatives for Enhanced Biological Activity and Stability},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202400979}
}
Kostenlos starten →